Literature DB >> 11158201

Regulation of neoplastic angiogenesis.

I J Fidler1.   

Abstract

The progressive growth of neoplasms and the production of metastasis depend on the development of adequate vasculature, i.e., angiogenesis. The extent of angiogenesis is determined by the balance between positive- and negative-regulating molecules that are released by tumor and host cells in the microenvironment. The growth of many neoplasms is associated with the absence of the endogenous inhibitor of angiogenesis, interferon beta (IFN beta). A survey of multiple mouse and human tumors shows a lack of IFN beta associated with extensive angiogenesis. Therapy with IFN alpha or beta either by subcutaneous injection of the protein or by introduction of viral vectors that contain the IFN beta gene inhibit angiogenesis and, hence, progressive tumor growth.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158201     DOI: 10.1093/oxfordjournals.jncimonographs.a024251

Source DB:  PubMed          Journal:  J Natl Cancer Inst Monogr        ISSN: 1052-6773


  11 in total

1.  A survey on herbal management of hepatocellular carcinoma.

Authors:  Nabil Mohie Abdel-Hamid; Maiiada Hasan Nazmy; Ahmed Wahid Mahmoud; Michael Atef Fawzy; Marco Youssof
Journal:  World J Hepatol       Date:  2011-07-27

2.  Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.

Authors:  Mian M K Shahzad; Jesusa M Arevalo; Guillermo N Armaiz-Pena; Chunhua Lu; Rebecca L Stone; Myrthala Moreno-Smith; Masato Nishimura; Jeong-Won Lee; Nicholas B Jennings; Justin Bottsford-Miller; Pablo Vivas-Mejia; Susan K Lutgendorf; Gabriel Lopez-Berestein; Menashe Bar-Eli; Steven W Cole; Anil K Sood
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

3.  Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway.

Authors:  Christian Korherr; Hendrik Gille; Rolf Schäfer; Kerstin Koenig-Hoffmann; Johan Dixelius; Kristi A Egland; Ira Pastan; Ulrich Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

Review 4.  Heterogeneity of tumor endothelial cells.

Authors:  Kyoko Hida; Noritaka Ohga; Kosuke Akiyama; Nako Maishi; Yasuhiro Hida
Journal:  Cancer Sci       Date:  2013-09-12       Impact factor: 6.716

5.  Physeal bystander effects in rhabdomyosarcoma radiotherapy: experiments in a new xenograft model.

Authors:  Jason A Horton; Judith A Strauss; Matthew J Allen; Timothy A Damron
Journal:  Sarcoma       Date:  2011-04-17

Review 6.  Targeting the Multidrug Transporter Ptch1 Potentiates Chemotherapy Efficiency.

Authors:  Anida Hasanovic; Isabelle Mus-Veteau
Journal:  Cells       Date:  2018-08-14       Impact factor: 6.600

7.  Serum immunoglobulin fused interferon-alpha inhibited tumor growth in athymic mice bearing colon 26 adenocarcinoma cells.

Authors:  Jun-Sung Kim; Kyeong Nam Yu; Mi Suk Noh; Min-Ah Woo; Sung-Jin Park; Jin Hong Park; Jin Hua; Hyun Sun Cho; Soon Kyung Hwang; Eun-Sun Lee; Youn-Sun Chung; In-Young Choi; Se-Chang Kwon; Myung-Haing Cho
Journal:  J Vet Sci       Date:  2008-03       Impact factor: 1.672

8.  Characterization of the melanoma brain metastatic niche in mice and humans.

Authors:  Moran Amit; Leonor Laider-Trejo; Vardit Shalom; Ayelet Shabtay-Orbach; Yakov Krelin; Ziv Gil
Journal:  Cancer Med       Date:  2013-03-11       Impact factor: 4.452

9.  Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 1.

Authors:  S M Sagar; D Yance; R K Wong
Journal:  Curr Oncol       Date:  2006-02       Impact factor: 3.677

10.  Dysregulated angiogenesis in B-chronic lymphocytic leukemia: morphologic, immunohistochemical, and flow cytometric evidence.

Authors:  John L Frater; Neil E Kay; Charles L Goolsby; Susan E Crawford; Gordon W Dewald; LoAnn C Peterson
Journal:  Diagn Pathol       Date:  2008-04-18       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.